BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30997873)

  • 1. Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients.
    Moleti ML; Al-Jadiry MF; Shateh WA; Al-Darraji AF; Mohamed S; Uccini S; Piciocchi A; Foà R; Testi AM; Al-Hadad S
    Leuk Lymphoma; 2019 May; 60(5):1224-1233. PubMed ID: 30997873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
    Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country.
    Moleti ML; Al-Hadad SA; Al-Jadiry MF; Al-Darraji AF; Al-Saeed RM; De Vellis A; Piciocchi A; Uccini S; Foà R; Testi AM
    Pediatr Blood Cancer; 2011 Apr; 56(4):560-7. PubMed ID: 21298740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
    Gerrard M; Cairo MS; Weston C; Auperin A; Pinkerton R; Lambilliote A; Sposto R; McCarthy K; Lacombe MJ; Perkins SL; Patte C;
    Br J Haematol; 2008 Jun; 141(6):840-7. PubMed ID: 18371107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre combined chemotherapy protocol for large cell advanced non Hodgkin's lymphoma.
    Dumont J; Charpy-Validire P; Mosseri V; Gabarre J; Belanger C; Turpin F; Binet JL; Dreyfus F; Fourquet A; Janvier M
    Hematol Oncol; 1991; 9(4-5):197-207. PubMed ID: 1720759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
    N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience.
    Chauhan P; Gupta A; Mandelia A; Yadav S; Rahman K; Nityanand S
    Pediatr Hematol Oncol; 2021 May; 38(4):305-318. PubMed ID: 33646922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
    Cortelazzo S; Rossi A; Viero P; Bellavita P; Marchioli R; Marfisi RM; Rambaldi A; Barbui T
    Br J Haematol; 1997 Nov; 99(2):379-85. PubMed ID: 9375759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
    Mazza P; Zinzani PL; Martelli M; Fiacchini M; Bocchia M; Pileri S; Falini B; Martelli MF; Amadori S; Papa G
    Leuk Lymphoma; 1995 Feb; 16(5-6):457-63. PubMed ID: 7540460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
    Diviné M; Casassus P; Koscielny S; Bosq J; Sebban C; Le Maignan C; Stamattoulas A; Dupriez B; Raphaël M; Pico JL; Ribrag V; ;
    Ann Oncol; 2005 Dec; 16(12):1928-35. PubMed ID: 16284057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
    Yoon JH; Kang HJ; Kim H; Lee JW; Park JD; Park KD; Shin HY; Ahn HS
    J Korean Med Sci; 2012 Nov; 27(11):1378-84. PubMed ID: 23166421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study.
    Lervat C; Auperin A; Patte C; Méchinaud F; Leverger G; Nelken B; Bertrand Y; Baruchel A; Coze C; Munzer M; Lacombe MJ; Bergeron C
    Pediatr Blood Cancer; 2014 Mar; 61(3):473-8. PubMed ID: 23970385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
    Baldini L; Guffanti A; Gobbi P; Colombi M; Federico M; Avanzini P; Cavanna L; Pieresca C; Silingardi V; Maiolo AT
    Cancer; 1997 Mar; 79(6):1234-40. PubMed ID: 9070503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.
    Pytlík R; Belada D; Kubáčková K; Vášová I; Kozák T; Pirnos J; Bolomská I; Matuška M; Přibylová J; Campr V; Burešová L; Sýkorová A; Berková A; Klener P; Trněný M;
    Leuk Lymphoma; 2015 Jan; 56(1):57-64. PubMed ID: 24628294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study.
    Sullivan MP; Brecher M; Ramirez I; Ragab A; Hvizdala E; Pullen J; Shuster J; Berard C; Crist W; Vietti T
    Am J Pediatr Hematol Oncol; 1991; 13(3):288-95. PubMed ID: 1793154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression.
    Blay JY; Bouhour D; Carrie C; Bouffet E; Brunat-Mentigny M; Philip T; Biron P
    Blood; 1995 Oct; 86(8):2922-9. PubMed ID: 7579384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results with MACOP-B in the treatment of aggressive non-Hodgkin's lymphomas. The experience in Brazil.
    Costa MA; Rabinowits M; Froimtchuk MJ; Olivatto LO; Allan SE; Gil RA; Andrade CA; Martino JL; Dobbin JA; Carriço MK
    Am J Clin Oncol; 1994 Aug; 17(4):323-7. PubMed ID: 7519390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.